Robert Carlson Ph.D Overview
- Firm
- Planetary Techno...
- Primary Position
-
Managing Directo...
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Robert Carlson Ph.D General Information
Biography
Dr. Robert Carlson serves as Managing Director at Bioeconomy Capital. He also serves as Board Member at Lumen Bioscience, RoosterBio, and Parse Biosciences. He serves as Board Observer at Cyclic Materials and Tandem PV. He is an Angel Investor. He is an entrepreneur, author, and scientist. The namesake of "Carlson Curves" and originator of the first estimates of global biotech revenues. He is the author of the book Biology is Technology: The Promise, Peril, and New Business of Engineering Life, published in 2010 by Harvard University Press; it received the PROSE award for the Best Engineering and Technology Book of 2010 and was named to the Best Books of 2010 lists by writers at both The Economist and Foreign Policy. He earned a doctorate in Physics from Princeton University in 1997.
Contact Information
Address
- 3417 Evanston Avenue North
- Suite 329
- Seattle, WA 98103
- United States
Robert Carlson Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Planetary Technologies | Investor | Managing Director | Seattle, WA | Venture Capital |
Robert Carlson Ph.D Board Seats (3)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Cyclic Materials | Environmental Services (B2B) | Privately Held (backing) | Venture Capital-Backed | Toronto, Canada | |
| Lumen Bioscience | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Seattle, WA | |
| RoosterBio | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Frederick, MD |
Robert Carlson Ph.D Lead Partner on Deals (6)
Robert Carlson Ph.D has been the lead partner on 6 deals. Their latest deal was with Parse Biosciences, a other healthcare technology systems company. The deal was made for on 26-Jan-2021.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Parse Biosciences | 26-Jan-2021 | Early Stage VC (Series A) | Completed | Other Healthcare Technology Systems | Seattle, WA | |
| Lumen Bioscience | 01-Sep-2020 | Completed | Drug Discovery | Seattle, WA | ||
| RoosterBio | 10-Sep-2019 | Completed | Biotechnology | Frederick, MD | ||
| Lumen Bioscience | 05-Aug-2017 | Completed | Drug Discovery | Seattle, WA | ||
| RoosterBio | 27-Feb-2017 | Early Stage VC (Series A2) | Completed | Biotechnology | Frederick, MD | |
| RoosterBio | 30-Dec-2014 | Early Stage VC | Completed | Biotechnology | Frederick, MD |
Robert Carlson Ph.D Network (60)
Board Members (29)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Micah Siegal | RoosterBio | Self | Frederick, MD | |
| Samuel Bursten | Cyclic Materials | Energy Impact Partners | Toronto, Canada | |
| Cyclic Materials | Self | Toronto, Canada | ||
| Lumen Bioscience | Lumen Bioscience | Seattle, WA | ||
| RoosterBio | Dynamk Capital | Frederick, MD |
Portfolio Executives (30)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Georg Seelig | Parse Biosciences | Co-Founder | 26-Jan-2021 | Seattle, WA |
| Alexander Rosenberg Ph.D | Parse Biosciences | Co-Founder, Chief Executive Officer & Board Member | 26-Jan-2021 | Seattle, WA |
| Parse Biosciences | Chief Technology Officer & Co-Founder | 26-Jan-2021 | Seattle, WA | |
| Lumen Bioscience | Chief Scientific Officer & Board Member | 01-Sep-2020 | Seattle, WA | |
| Lumen Bioscience | Co-Chief Financial Officer & Advisor | 01-Sep-2020 | Seattle, WA |
Fund Team Members (1)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Rik Wehbring | Planetary Technologies | Planetary Technologies Fund 3 | Seattle, WA |
| Rik Wehbring | Planetary Technologies | Bioeconomy Fund 2 | Seattle, WA |
| Planetary Technologies | Seattle, WA |
Robert Carlson Ph.D Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Planetary Technologies Fund 3 | Planetary Technologies | Venture Capital - Early Stage | Open | |||||
| Bioeconomy Fund 2 | Planetary Technologies | Venture Capital - Early Stage | Closed | 2020 | ||||
| Bioeconomy Fund 1 | Planetary Technologies | Venture Capital - Early Stage | Fully Invested | 2015 |
Robert Carlson Ph.D FAQs
-
Who is Robert Carlson Ph.D?
Dr. Robert Carlson serves as Managing Director at Bioeconomy Capital.
-
How much does Robert Carlson Ph.D typically invest?
Robert Carlson Ph.D's median deal size is .
-
What is Robert Carlson Ph.D’s main position?
Robert Carlson Ph.D’s primary position is Managing Director.
-
What are the contact details for Robert Carlson Ph.D?
Robert Carlson Ph.D’s email address is ro and his phone number is +1 (415) .
-
How many active board seats does Robert Carlson Ph.D hold?
Robert Carlson Ph.D holds 3 board seats including Cyclic Materials, Lumen Bioscience, and RoosterBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
